Get the Stockscreener App
2.78
0.00%
0.00
Pre-market:
2.65
-0.13
-4.68%
Avalon Globocare Corp stock is traded at $2.78, with a volume of 20,307.
It is up +0.00% in the last 24 hours and up +2.96% over the past month.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
See More
Previous Close:
$2.78
Open:
$2.75
24h Volume:
20,307
Relative Volume:
0.03
Market Cap:
$2.89M
Revenue:
$1.23M
Net Income/Loss:
$-9.23M
P/E Ratio:
-1.9716
EPS:
-1.41
Net Cash Flow:
$-7.69M
1W Performance:
-10.90%
1M Performance:
+2.96%
6M Performance:
-39.81%
1Y Performance:
-65.99%
1-Day Range:
$2.6905
$2.87
1-Week Range:
$2.53
$3.27
52-Week Range:
$2.11
$21.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Name
Avalon Globocare Corp
Sector
Industry
Phone
732-780-4400
Address
4400 ROUTE 9, FREEHOLD
Compare ALBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ALBT | 2.78 | 2.89M | 1.23M | -9.23M | -7.69M | -1.41 |
| CBRE | 131.78 | 40.20B | 34.31B | 958.00M | 913.00M | 1.87 |
| CSGP | 76.27 | 31.27B | 2.67B | 175.40M | -61.90M | 0.99 |
| BEKE | 20.23 | 24.44B | 10.09B | 577.32M | 1.05B | 0.6126 |
| JLL | 256.62 | 12.20B | 21.75B | 382.60M | 471.40M | 4.71 |
| FSV | 188.44 | 8.50B | 4.93B | 108.16M | 203.45M | 2.96 |
Avalon Globocare Corp Stock (ALBT) Latest News
Avalon launches ‘BrAce for Impact’ affiliate marketing program - TipRanks
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device - GlobeNewswire
Avalon GloboCare Launches AI-Powered KetoAir™ Affiliate Program for Ketosis Monitoring | ALBT Stock News - StockTitan
Critical Review: Innate Pharma (NASDAQ:IPHA) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023) - Yahoo Finance
Avalon GloboCare Corp. (ALBT) Quarterly 10-Q Report - Quartzy
U.S. Stock market: Zoomcar Holdings (+192.21%), Avalon GloboCare (+56.73%), and Vimeo (+40.85%) experience significant gains during mid day trading - Business Upturn
U.S. Stock market: Zoomcar Holdings up 87.10%, Avalon GloboCare jumps 57.14%, Vimeo rises 44.07% among top gainers - Business Upturn
U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges - Investing.com Canada
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges By Investing.com - Investing.com South Africa
Avalon GloboCare Appoints Dr. Charles Cavo to Scientific Advisory Board Support for KetoAir Sales - Defense World
Avalon GloboCare faces Nasdaq delisting after rule breach By Investing.com - Investing.com South Africa
Avalon GloboCare faces Nasdaq delisting after rule breach - Investing.com India
Avalon appoints Cavto to Scientific Advisory Board - TipRanks
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - GlobeNewswire
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares By Investing.com - Investing.com South Africa
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares - Investing.com
Avalon Globocare stock hits 52-week high at $3.45 By Investing.com - Investing.com South Africa
500: Something went wrong - Investing.com UK
Avalon Globocare stock hits 52-week high at $3.45 - Investing.com India
Avalon GloboCare Stock Set to Reverse Split on Monday, October 28th (NASDAQ:ALBT) - Defense World
Avalon GloboCare Collaborates for Cannabis Breathalyzer Development - TipRanks
Avalon, enters MOU with Qi Diagnostics - TipRanks
Avalon GloboCare and Qi Diagnostics Enter into Memorandum - GlobeNewswire
Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving - StockTitan
EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer - Yahoo Finance
Avalon GloboCare to enact reverse stock split By Investing.com - Investing.com Australia
Avalon GloboCare to enact reverse stock split - Investing.com
Avalon GloboCare Announces 1-for-15 Reverse Stock Split - citybiz
ALBTAvalon GloboCare Corp. Latest Stock News & Market Updates - StockTitan
Avalon GloboCare Announces Reverse Stock Split Strategy - TipRanks
Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan - GlobeNewswire
Avalon Globocare (ALBT-Q) QuotePress Release - The Globe and Mail
Avalon Globocare stock hits 52-week low at $0.19 - Investing.com
Avalon Globocare stock hits 52-week low at $0.19 By Investing.com - Investing.com UK
Avalon GloboCare announces key shareholder decisions - Investing.com India
Avalon GloboCare announces key shareholder decisions By Investing.com - Investing.com UK
Examining Avalon GloboCare Corp (ALBT) more closely is necessary - US Post News
Avalon GloboCare Corp (ALBT) Stock: A Year of Highs and Lows - The InvestChronicle
Avalon GloboCare Showcases KetoAir™ at Keto Conference - TipRanks
Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device - The Manila Times
Acumen Health Holdings to Acquire Avenova Brand Enhancing Eye Health Portfolio - MyChesCo
Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM) is Libra Wealth LLC’s 7th Largest Position - Defense World
Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals - PR Newswire
Avalon Globocare stock hits 52-week low at $0.2 - Investing.com India
Avalon Globocare stock hits 52-week low at $0.2 By Investing.com - Investing.com Canada
Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I - ForexTV.com
ALBT’s Stock Market Adventure: -57.35% YTD Growth Amidst Volatility - The InvestChronicle
Gabon Seeks Cameroon’s Support for ASECNA Director Election - Business in Cameroon
Avalon Globocare Corp Stock (ALBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.83%
2.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):